|
Before the 1930s, even minor infections — strep throat, for example — were life-threatening. The introduction
of antibiotics changed that. Not only did these drugs dramatically increase the length and quality of human life, but they
also enabled practices now considered to be central to modern medicine (e.g., surgery). The emergence of drug-resistant
bacteria, however, threatens to undo these dramatic medical advances, potentially restoring common bacteria to their
historical role as a significant threat to human health.
Achaogen is pursuing unique strategies to combat these drug-resistant pathogens. Our scientific strategy is without precedent
and represents a fundamentally new approach to address this growing healthcare crisis.
Achaogen is backed by top-tier investors and staffed by a dynamic team of
scientists. Our state-of-the-art research facility is located on the shores of the San Francisco
Bay, five minutes from the San Francisco International Airport, and only fifteen minutes from San Francisco.
|
